NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView is pleased to announce an exclusive Q&A...
Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma PR...
Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor®...
A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference PR Newswire PRINCETON...
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView, a leader within the financial markets and news...
Soligenix Announces Reverse Stock Split PR Newswire PRINCETON, N.J., May 31, 2024 Common Stock Will Begin...
Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting PR Newswire PRINCETON, N.J., May...
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting PR...
Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split PR Newswire PRINCETON, N.J., May...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.